Sector is Expected to Reach $5.24 Billion by 2032

Home Sector is Expected to Reach $5.24 Billion by 2032
Written by Doug Hampton
On

DUBLIN, June 14, 2023 /PRNewswire/ — The “Glycomics/Glycobiology Market Share, Size, Trends, Industry Analysis Report, By Product , By Application, By End-Use, By Region, Segment Forecast, 2023 – 2032” report has been added to  ResearchAndMarkets.com’s offering.

The global glycomics/glycobiology market size is expected to reach USD 5.24 billion by 2032, according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising investments and implementation on glycomics research by both government and private organizations, high development of many novel drugs & therapeutics, and progress in proteomics are key factors boosting global market growth.

In the last decades, glycomics has gained high popularity as an emerging field of research and has a wide range of applications in oncology, diagnostics, drug discovery, and immunology and is also being used in determining cancer cells and regulating cell regulation.

Thus, the market is expected to grow significantly and have huge opportunities shortly. For instance, in April 2022, Bruker announced the availability of its new novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF flex combined with unbiased lipidomics, metabolomics, and glycomics tissue imaging.

The growing prevalence of cancer and other related diseases among people worldwide has led to the rising use of glycobiology in research activities for cancer treatment, because of the relevance of surface glycan in both neoplastic and metastatic characteristics of tumor cells present in human body. Lung cancer amounted to a leading number of cancer deaths, with a total estimated 1.8 million deaths followed by colorectal with about 1 million deaths.

Furthermore, precision medicine has rapidly grown in recent years and many large pharma and biotech companies are investing larger funds to develop various targeted drugs, which can be effectively used for a specific patient group. In addition, a researcher has also shown that the mutation in glycosyltransferases or other related enzymes alters the glycome and also causes over 100 types of human congenital disorders.

Companies Mentioned

  • Thermo Fisher Scientific
  • Merck KGaA
  • Agilent Technology
  • New England Biolabs
  • Danaher Corporation
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Waters Corporation
  • Sumitomo Bakelite Co. Ltd.
  • AMS Bio
  • Kode Biotech Limited
  • Ray Biotech Life Inc.
  • Lectenz Bio
  • Glycomix Ltd.
  • Ludger Ltd.
  • Glyxera GmbH
  • IEC Group

Glycomics/Glycobiology Market Report Highlights

  • Instruments segment accounted for largest market share in 2022 on account of increasing adoption of innovative instruments across various applications including diagnostics
  • Drug discovery & development segment held the largest market revenue share in 2022, owing to the increase in prevalence of personalized medicine to address chronic diseases
  • Pharmaceutical & biotechnology companies are likely to be the largest end-use segment over the forecast period due to the increased investment and efforts by the companies on technology development and product enhancement.
  • North America dominated the global market in 2022, which is highly attributed to the growing proliferation of precision medicine and increasing healthcare spending in countries like the US and Canada.

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Glycomics/Glycobiology Market Insights
4.1. Glycomics/Glycobiology Market – End Use Snapshot
4.2. Glycomics/Glycobiology Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Technological advancements
4.2.1.2. Rising investments in R&D of pharmaceutical and biotechnology companies
4.2.2. Restraints and Challenges
4.2.2.1. High cost of tools
4.3. Porter’s Five Forces Analysis
4.4. PESTEL Analysis
4.5. Glycomics/Glycobiology Market End Use Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Glycomics/Glycobiology Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
5.3. Enzymes
5.3.1. Global Glycomics/Glycobiology Market, by Enzymes, by Region, 2019-2032 (USD Billion)
5.4. Kits
5.4.1. Global Glycomics/Glycobiology Market, by Kits, by Region, 2019-2032 (USD Billion)
5.5. Reagents
5.5.1. Global Glycomics/Glycobiology Market, Reagents, by Region, 2019-2032 (USD Billion)
5.6. Instruments
5.6.1. Global Glycomics/Glycobiology Market, Instruments, by Region, 2019-2032 (USD Billion)

6. Global Glycomics/Glycobiology Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. Global Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
6.3. Drug Discovery & Development
6.3.1. Global Glycomics/Glycobiology Market, by Drug Discovery & Development, by Region, 2019-2032 (USD Billion)
6.4. Diagnostics
6.4.1. Global Glycomics/Glycobiology Market, by Diagnostics, by Region, 2019-2032 (USD Billion)
6.5. Others
6.5.1. Global Glycomics/Glycobiology Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Glycomics/Glycobiology Market, by End Use
7.1. Key Findings
7.2. Introduction
7.2.1. Global Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
7.3. Academic & Research Institute
7.3.1. Global Glycomics/Glycobiology Market, by Academic & Research Institute, By Region, 2019-2032 (USD Billion)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Global Glycomics/Glycobiology Market, by Pharmaceutical & Biotechnology Companies, By Region, 2019-2032 (USD Billion)
7.5. CROS
7.5.1. Global Glycomics/Glycobiology Market, by CROS, By Region, 2019-2032 (USD Billion)

8. Global Glycomics/Glycobiology Market, by Geography

9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/1j5sui

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716 

Logo:  https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg 

SOURCE Research and Markets

Leave a Comment